MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/β-catenin signaling pathway

Biochemical and Biophysical Research Communications

Volumn 420, Issue 4, 2012, Pages 875-881

  Zhang, Lu lu ^a   Liu, Jing jin ^a   Liu, Fang ^a   Liu, Wen hua ^a   Wang, Yong shun ^a   Zhu, Bin ^a   Yu, Bo ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac differentiation; Mesenchymal stem cells; MiR 499; Wnt catenin signaling pathway

Indexed keywords

ALPHA ACTININ 1; BETA CATENIN; DISHEVELLED PROTEIN; LENTIVIRUS VECTOR; MICRORNA; MIR 499; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HEART; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; MESENCHYMAL STEM CELLS; MICRORNAS; MYOCYTES, CARDIAC; RATS; SIGNAL TRANSDUCTION; WNT PROTEINS;

RATTUS;

EID: 84859854920     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.092     Document Type: Article

References (38)

1. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
2. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
3. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
4. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999 Mar, 103:697-705.
5. Y.L. Tang, Q. Zhao, X. Qin, et al., Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction, Ann. Thorac. Surg. 80 (2005) 229-236; discussion 236-7.
6. Agbulut O., Menot M.L., Li Z., et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc. Res. 2003, 58:451-459.
7. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
8. Pillai R.S. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 2005, 11:1753-1761.
9. Zamore P.D., Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524.
10. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33:1290-1297.
11. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
12. Guo L., Zhao R.C., Wu Y. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp. Hematol. 2011, 39:608-616.
13. Chen J.F., Mandel E.M., Thomson J.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
14. Anderson C., Catoe H., Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006, 34:5863-5871.
15. Sun Q., Zhang Y., Yang G., et al. Transforming growth factor-beta regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res. 2008, 36:2690-2699.
16. Naguibneva I., Ameyar-Zazoua M., Polesskaya A., et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol. 2006, 8:278-284.
17. Boutz P.L., Chawla G., Stoilov P., Black D.L. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev. 2007, 21:71-84.
18. Kloosterman W.P., Steiner F.A., Berezikov E., et al. Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Res. 2006, 34:2558-2569.
19. Landgraf P., Rusu M., Sheridan R., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
20. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genom. 2007, 8:166.
21. Reddy A.M., Zheng Y., Jagadeeswaran G., et al. Cloning, characterization and expression analysis of porcine microRNAs. BMC Genom. 2009, 10:65.
22. Sluijter J.P., van Mil A., van Vliet P., et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:859-868.
23. van Rooij E., Quiat D., Johnson B.A., et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell. 2009, 17:662-673.
24. Bell M.L., Buvoli M., Leinwand L.A. Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol. Cell Biol. 2010, 30:1937-1945.
25. Hosoda T., Zheng H., Cabral-da-Silva M., et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 2011 Mar, 123:1287-1296.
26. Wilson K.D., Hu S., Venkatasubrahmanyam S., et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ. Cardiovasc. Genet. 2010, 3:426-435.
27. Fu J.D., Rushing S.N., Lieu D.K., et al. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One 2011, 6:e27417.
28. Paige S.L., Osugi T., Afanasiev O.K., et al. Endogenous wnt/b-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 2010, 5:e11134.
29. Nakamura T., Sano M., Songyang Z., Schneider M.D. A Wnt and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:5834-5839.
30. Naito A.T., Akazawa H., Takano H., et al. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical wnt signaling. Circ. Res. 2005, 97:144-151.
31. Malbon C.C., Wang H.Y. Dishevelled: a mobile scaffold catalyzing development. Curr. Top Dev. Biol. 2006, 72:153-166.
32. Yost C., Torres M., Miller J.R., et al. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 1996, 10:1443-1454.
33. Kimelman D., Xu W. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006, 25:7482-7491.
34. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
35. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
36. Mundel P., Heid H.W., Mundel T.M., et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol. 1997, 139:193-204.
37. Iguchi H., Urashima Y., Inagaki Y., et al. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J. Biol. Chem. 2007, 282:19052-19061.
38. Liu C., Li Y., Semenov M., et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.